title: Strategies for enhancing antibody delivery to the brain.
abstract: Antibodies and antibody conjugates have emerged as important tools for cancer therapy. However, a major therapeutic challenge for the use of antibodies is their inability to cross the blood-brain barrier (BBB) to reach tumors localized in the central nervous system (CNS). Multiple methods have been developed to enhance antibody delivery to the CNS, including direct injection, mechanical or biochemical disruption of the BBB, conjugation to a 'molecular Trojan horse', cationization, encapsulation in nanoparticles and liposomes, and more recently, stem cell-mediated antibody delivery. In this review, we discuss each of these approaches, highlighting their successes and the obstacles that remain to be overcome.
authors.affiliation: Department of Neurosciences, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA 91010, USA. rikfrank@gmail.com
authors.forename: Richard T
authors.initials: RT
authors.lastname: Frank
authors.forename: Karen S
authors.initials: KS
authors.lastname: Aboody
authors.forename: Joseph
authors.initials: J
authors.lastname: Najbauer
mesh_terms: D000818:Animals; D000906:Antibodies / Q000008:administration & dosage* / Q000378:metabolism; D001812:Blood-Brain Barrier; D001921:Brain / Q000378:metabolism*; D004058:Diffusion; D006801:Humans; D008081:Liposomes; D053758:Nanoparticles; D013234:Stem Cells / Q000502:physiology; D057900:Transcytosis
chemical_list: D000906:Antibodies; D008081:Liposomes